Monkeypox Diagnostic Testing and Vaccines: Hold Claims
In a July 26, 2022, press release, the American Medical Association (AMA) announced new CPT codes related to Monkeypox diagnostic testing and vaccination.
The Office of MaineCare Services (OMS) will be updating our system to include these codes and ask that all claims be held until the update is complete.
Please review the following table for more information.
Monkeypox Diagnostic Testing and Vaccination Codes |
|||
Code |
Description |
Effective Date |
MaineCare Rate |
|
87593 |
Infectious agent detection by nucleic acid (DNA or RNA); orthopoxvirus (eg, monkeypox virus, cowpox virus, vaccinia virus), amplified probe technique, each |
07/26/22 |
TBD* |
|
90611 |
Smallpox and monkeypox vaccine, attenuated vaccinia virus, live, non-replicating, preservative free, 0.5 mL dosage, suspension, for subcutaneous use |
07/26/22 |
TBD* |
|
90622 |
Vaccinia (smallpox) virus vaccine, live, lyophilized, 0.3 mL dosage, for percutaneous use |
07/26/22 |
TBD* |
|
*Rates for these codes are not yet established |
|||
Please contact your Provider Relations Specialist with questions.
Check out our new MaineCare logo! Learn more about this logo on the About Us page of our website.
